Skip to main content

Table 5 Bayesian AFT model using INLA methods Results of outpatients with cervical cancer, UoGRH, 2018–2022

From: Assessing survival time of outpatients with cervical cancer: at the university of Gondar referral hospital using the Bayesian approach

Parameter

Pmean

Sd

median

Credible Interval

Mode

Kld

Intercept

5.863

0.196

4.761

[5.446, 6.502]*

4.724

0

Baseline weight

 − 0.321

0.215

 − 0.401

[− 0.642, − 0.185]*

 − 0.399

0

Education(ref = literate)

      

 Illiterate

 − 0.178

0.123

 − 0.168

[− 0.392, 1.193]

 − 0.167

0

Histology(ref = Adenocarcinoma)

      

 Squamous cell

 − 0.299

0.062

 − 0.278

[− 0.427, − 0.154]*

 − 0.277

0

Stage (ref = early)

      

 Late

 − 0.331

0.114

 − 0.201

[− 0.442, − 0.053]*

 − 0.200

0

 HIV(ref = No)

      

 Yes

 − 0.282

0.046

 − 0.280

[− 0.388, − 0.053]*

 − 0.279

0

Oral contraceptive uses(ref = No)

      

 Yes

 − 0.243

0.062

 − 0.242

[− 0.299, − 0.018]*

 − 0.241

0

Comorbid disease (ref = No)

      

 Yes

 − 0.332

0.11

0.331

[− 0.531, − 0.136]*

 − 0.330

0

Metastasis number (ref = 0)

      

 1

 − 0.360

0.170

 − 0.297

[− 0.782, − 0.038]*

 − 0.282

0

 2

 − 0.373

0.166

 − 0.319

[− 0.761, − 0.190]*

 − 0.312

0

 >  = 3

 − 0.385

0.163

 − 0.401

[− 0.857, − 0.180]*

 − 0.392

0

Differentiation grade (ref = 1)

      

 Grade 2

 − 0.517

0.180

 − 0.297

[− 0.792, − 0.068]*

 − 0.289

0

 Grade 3

 − 0.523

0.166

 − 0.319

[− 0.781, − 0.090]*

 − 0.310

0

 Grade 4

 − 0.530

0.150

 − 0.344

[− 0.844, − 0.140]*

 − 0.346

0

History of abortion (ref = No)

      

 Yes

 − 0.205

0.112

 − 0.205

[− 0.418, − 0.096]*

 − 0.204

0

Regional nodes examined (ref = No)

      

 Yes

 − 0.232

0.10

0.231

[− 0.431, − 0.036]*

 − 0.230

0

Regional nodes (ref = negative)

      

 Positive

 − 0.432

0.15

0.332

[− 0.831, − 0.236]*

 − 0.330

0

Chemotherapy (ref = No)

      

 Yes

 − 0.422

0.086

 − 0.421

[− 0.593, − 0.255]*

 − 0.419

0

Radiation (ref = Beam Radiation)

      

 Brachytherapy

 − 0.158

0.113

 − 0.158

[− 0.382, 1.143]

 − 0.157

0

 BRB

 − 0.381

0.160

 − 0.381

[− 0.693, − 0.066]*

 − 0.382

0

FIGO (ref = IA1)

      

 IA2

 − 0.400

0.190

 − 0.397

[− 0.782, − 0.039]*

 − 0.389

0

 IB1

 − 0.423

0.188

 − 0.410

[− 0.781, − 0.090]*

 − 0.405

0

 IB2

 − 0.426

0.185

 − 0.423

[− 0.780, − 0.042]*

 − 0.421

0

 IIA

 − 0.436

0.183

 − 0.437

[− 0.778, − 0.094]*

 − 0.438

0

 IIB

 − 0.460

0.180

 − 0.448

[− 0.788, − 0.124]*

 − 0.453

0

 IIIA

 − 0.471

0.177

 − 0.463

[− 0.791, − 0.154]*

 − 0.466

0

 IIIB

 − 0.499

0.175

 − 0.484

[− 0.823, − 0.164]*

 − 0.486

0

 IV

 − 0.506

0.173

 − 0.501

[− 0.857, − 0.180]*

 − 0.492

0

Smoking status(ref = No)

      

 Yes

 − 0.168

0.143

 − 0.158

[− 0.282, 1.063]

 − 0.157

0

LVSI (ref = No)

      

 Yes

 − 0.336

0.110

 − 0.335

[− 0.557, − 0.125]*

 − 0.331

0

Tumor size (ref =  < 4 cm)

      

 >  = 4 cm

 − 0.258

0.115

 − 0.257

[− 0.486, − 0.035]*

 − 0.255

0

Tau parameter(log − normal)

4.19

0.497

4.18

[3.29, 5.27]*

4.15

_

  1. *indicated statistically significant at 5%. Pmean, Posterior Mean; Sd, Standard deviation; Kld, Kullback–Leibler divergence